MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association
- PMID: 29650800
- PMCID: PMC5981170
- DOI: 10.1182/blood-2018-02-834689
MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Comment on
-
How I manage monoclonal gammopathy of undetermined significance.Blood. 2018 Jan 11;131(2):163-173. doi: 10.1182/blood-2017-09-807560. Epub 2017 Nov 28. Blood. 2018. PMID: 29183887 Free PMC article. Review.
References
-
- Mehta A, Belmatoug N, Bembi B, et al. Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Mol Genet Metab. 2017;122(3):122-129. - PubMed
-
- Thomas AS, Mehta AB, Hughes DA. Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists. Blood Cells Mol Dis. 2013;50(3):212-217. - PubMed
-
- Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007;82(8):697-701. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
